Orchid Pharma Ltd., a key player in the pharmaceutical industry, specializes in the manufacturing and export of bulk drugs, or Active Pharmaceutical Ingredients (APIs). The company is well-regarded fo... Orchid Pharma Ltd., a key player in the pharmaceutical industry, specializes in the manufacturing and export of bulk drugs, or Active Pharmaceutical Ingredients (APIs). The company is well-regarded for its expertise in the production of a broad spectrum of antibiotics, spanning penicillin, cephalosporins, and non-antibiotics that cater to global markets. Alongside its API offerings, Orchid Pharma has expanded its portfolio to include formulations, providing essential medications in various dosage forms ready for the end-user market. This diversification underscores its commitment to addressing diverse global health care needs. Established as a robust supplier in both domestic and international pharmaceutical sectors, Orchid Pharma's operations are backed by a strong emphasis on scientific innovation, regulatory compliance, and ethical practices. Its products impact several therapeutic segments including infective care and cardiovascular treatments. Through strategic partnerships and an extensive distribution network, Orchid Pharma plays a vital role in the healthcare supply chain, contributing significantly to global medicine availability and standards.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Orchid Pharma

We reviewed Orchid Pharma's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Orchid Pharma's data?

Start your 30-day free trial to request a data review for Orchid Pharma.

Start Free Trial

Legal Center Contact Us